Hamlet BioPharma AB Logo

Hamlet BioPharma AB

Developing selective therapies for cancer and infections like bladder cancer and UTIs.

HAMLET | SPGR

Overview

Corporate Details

ISIN(s):
SE0015661145 (+2 more)
LEI:
549300HJV2LJY4CDBR64
Country:
Sweden
Address:
Klinikgatan 32, 222 42 LUND
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Hamlet BioPharma AB is a clinical-stage pharmaceutical company developing novel therapies for cancer and infections. Its lead oncology candidate, Alpha1H, is a tumor-killing protein-lipid complex designed to selectively target and eliminate tumor cells while sparing healthy tissue. Alpha1H has successfully completed Phase II trials for bladder cancer, demonstrating significant tumor reduction and immune system activation. The company is also advancing immunotherapy as an alternative to antibiotics. Its IL-1 inhibitor, anakinra, has completed Phase II studies showing positive results in treating patients with recurrent urinary tract infections and Bladder Pain Syndrome (interstitial cystitis). Hamlet BioPharma's pipeline focuses on creating highly specific treatments with improved safety profiles for significant unmet medical needs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Hamlet BioPharma AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hamlet BioPharma AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HVIVO PLC Logo
A CRO running human challenge trials to test infectious disease vaccines for pharma/biotech clients.
United Kingdom HVO
Iconovo AB Logo
Develops inhaled therapies and patented dry powder inhalers for global pharma partners.
Sweden ICO
IMMUPHARMA PLC Logo
Develops novel peptide therapeutics for autoimmune diseases like Lupus (SLE) and CIDP.
United Kingdom IMM
Inhalation Sciences Sweden AB Logo
Inhalation research instruments and CRO services for preclinical pharma/biotech development.
Sweden ISAB
Initiator Pharma A/S Logo
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
Denmark INIT
IXICO PLC Logo
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom IXI
J. Molner AS Logo
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia JML
LYSOGENE Logo France LYS
Mazaro N.V. Logo
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium MLMAZ
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR

Talk to a Data Expert

Have a question? We'll get back to you promptly.